All posts by imreal

Point-of-Care Partners Announces Pooja Babbrah’s Election to the 2020-2021 NCPDP Board


Pooja Babbrah

Pooja Babbrah, MBA

Today, Point-of-Care Partners announced that Pooja Babbrah, MBA, PBM Practice Lead, has been elected to the NCPDP 2020-2021 Board of Trustees. Pooja will assume her new role at the NCPDP Board of Trustees meeting on Wednesday, May 6, 2020.

“Pooja brings a unique blend of broad health IT expertise to the NCPDP Board. Her efforts were instrumental in NCPDP’s formation of its Specialty Pharmacy Work Group, where she has served as co-chair since 2018. Under her co-leadership, this workgroup has achieved milestones in Specialty ePrescribing that took decades to achieve for ePrescribing of non-Specialty medications,” said Tony Schueth, CEO and Managing Partner of Point-of-Care Partners. “Point-of-Care Partners has a long history of supporting NCPDP through leadership roles that have contributed to widespread industry adoption of ePrescribing and electronic prior authorization. I’m excited we can continue to support healthcare’s transformation through Pooja’s participation as a board member and as a company continue to help pioneer NCPDP’s growing role in advancing standards to support healthcare interoperability and value-based care.”

Pooja currently serves as Point-of-Care Partners’ Practice Lead for PBM Services. She has worked with all ePrescribing stakeholders including PBMs, health plans, patients, physicians, ePrescribing and EMR vendors and hospitals/health systems. Her efforts have been instrumental in bringing more relevant and critical information into the ePrescribing workflow encompassing prior authorization, real-time benefit check, clinical messaging and eEnrollment forms including specialty pharmacy, patient assistance program enrollment, and other types of forms related to prescribing that are currently being handled manually. Her recent efforts to advance industry adoption of real-time benefit check included the March 2019 Senate testimony where she answered how the real-time pharmacy benefit check transaction can contribute to drug price transparency. In addition, she has contributed to efforts to advance industry adoption of consumer-facing real-time benefit as an industry spokesperson for the CARIN Alliance.

“I’m honored to serve on the NCPDP Board of Trustees, working with industry leaders to advance NCPDP’s new, Three-Year Strategic Plan. I’ve seen the positive impact that standards organizations, and particularly NCPDP has had over the past two decades in the healthcare technology space. Our industry continues to change and grow, and I’m excited to be part of the NCPDP story and to help the organization as we navigate this new, constantly changing landscape.”

About Point-of-Care Partners

Point-of-Care Partners is a leading health IT management consulting firm with in-depth expertise in ePrescribing, eMedication management, health information exchange, population health management and multi-stakeholder initiatives. To learn more about how Point-of-Care Partners can help your company understand the changing health care landscape and implement effective strategies, contact info@pocp.com.

Related Links:

NCPDP Reports Election Results for Its Board of Trustees

Pooja Babbrah Testimony: Senate Special Committee Hearings, March 7, 2019, The Complex Web of Prescription Drug Prices: Untangling the Web and Paths Forward

Share article on social media or email:

Goliath Technologies Appoints Karen Armor as Senior Vice President of Worldwide Sales


Armor, veteran high-tech sales executive, will drive next phase of revenue growth

“I am particularly excited to join an organization with incredible technology, successful industry veterans, and a corporate culture that is passionate about solving complex IT challenges with software.”

End-User Experience Monitoring and Troubleshooting Leader Adds Proven Sales Executive to Propel Next Phase of Growth

Goliath Technologies, a leader in end-user experience monitoring and troubleshooting software, announced today the appointment of Karen Armor to Senior Vice President of Worldwide Sales. Armor, a veteran high-tech leader and sales executive, will spearhead the entire global sales organization, including client success, to help drive the company’s next phase of growth.

Armor is a talented sales and operations leader with extensive experience in growing software companies. She joins Goliath following her most recent role as Senior Vice President of Worldwide Sales at 5Nine, a leader in hybrid cloud virtualization management and security, which was acquired by Acronis in December of 2019. Her experience in sales, customer retention and deployment, and maximizing traditional and next generation sales functions has given her the knowledge and insight to accelerate top line revenue and client satisfaction across business-to-business software companies.

“I am thrilled to have Karen join the Goliath team. Her background and skillset are exactly what is needed to support us in our next phase of revenue growth,” said Thomas Charlton, Chairman and CEO of Goliath Technologies. “I can’t imagine a more challenging time to assume the role of sales leader given the current COVID-19 health crisis. That said, the entire team at Goliath is very motivated at this critical time because our technology positively impacts patient care in health systems and offers business continuity for all organizations by enabling remote workforces to be highly productive at home contributing to the avoidance of layoffs.”

At Goliath, Armor will join a leadership team that recently added technology veteran Stacy Leidwinger as Chief Marketing Officer and Donna Grare as Executive Vice President and CTO. With a complete executive team, Charlton has the support he needs to drive growth by leveraging a continued focus on software that helps IT teams to deal with the inherent complexities of managing hybrid IT environments regardless of where applications, infrastructure, or end users are located.

“It is an exciting time to join an organization that is delivering great value, especially to the health systems who are on the front lines fighting this pandemic,” says Armor, Sr. VP of Worldwide Sales at Goliath Technologies. “I am particularly excited to join an organization with incredible technology, successful industry veterans, and a corporate culture that is passionate about solving complex IT challenges with software.”

Prior to 5Nine, Armor served as Segment Business Unit Executive for IBM Security. In this role, she acted as the focal point for coordination between IBM and the North American Security Sales leadership, sellers, and customers. Before being acquired into IBM in 2013, she held notable leadership roles within both sales and operations at MaaS360/Fiberlink; including build-outs of high-performing enterprise and inside sales teams as well as integrated account management and customer success organizations

About Goliath Technologies

Goliath Technologies offers end-user experience monitoring and troubleshooting software, with embedded intelligence and automation, that enables IT pros to anticipate, troubleshoot, and document performance issues regardless of where workloads, applications, or users are located. By doing so, Goliath helps IT break out of reactive mode, and into proactive mode. Customers include Universal Health Services, NorthBay Healthcare, Enterprise Rent-A-Car, Penn National Insurance, Bank of America, American Airlines, Office Depot, Tech Mahindra, Pacific Life, Xerox, HCL, and others. Learn more about how we empower proactive IT at goliathtechnologies.com.

Share article on social media or email:

The Abdomen is the Best Donor Site for Natural Tissue Breast Reconstruction


Dr. Constance Chen

As more women undergo cosmetic surgery to improve the shape of their abdomens, they should realize that they are making decisions that will affect their ability to undergo natural tissue breast reconstruction if they develop breast cancer.

Every year, hundreds of thousands of women undergo surgical procedures to reshape their abdomens. For many, diet and exercise cannot correct the loose skin, stretch marks, and loss of elasticity that result from pregnancy, weight loss, or the aging process. Some women also suffer a weakening of abdominal muscles that causes a bulge that is equally resistant to efforts to reduce it. An abdominoplasty or tummy tuck removes excess skin and stretch marks and can also repair damaged muscles. The result is a flatter, firmer stomach and improved waistline. One issue that women undergoing abdominoplasty often fail to consider, however, is that the abdominal tissue is often the best donor site for natural tissue breast reconstruction.

Nobody plans to get breast cancer. Yet one in eight women (12%) will develop breast cancer over the course of her lifetime, and only 2.5% of women with breast cancer have a family history. The overwhelming majority of women who have breast cancer have no family history of the disease and no known genetic mutation to account for it. “We give women all the available information we have on how to reduce their risk of breast cancer,” says plastic surgeon and breast specialist Dr. Constance M. Chen. “We recommend a healthy diet, regular exercise, avoiding smoking and hormone replacement therapy, and following their doctor’s guidelines for mammograms and breast exams. Despite this, breast cancer strikes women who never expect it.”

As more women undergo cosmetic surgery to improve the shape of their abdomens, they should realize that they are making decisions that will affect their ability to undergo natural tissue breast reconstruction if they develop breast cancer. Women may consider cosmetic abdominoplasties in their 30s and 40s. Meanwhile, they may develop breast cancer in their 50s and 60s. “When women come in seeking the best possible breast reconstruction, they often realize they want natural tissue breast reconstruction,” says Dr. Chen. “To keep this option open, they need to avoid cosmetic abdominoplasties.”

The “gold standard” in reconstruction surgery, known as “perforator flaps,” uses microsurgical techniques to carefully separate muscle from the fat and skin that are used to form the new breast, replacing the fat and skin that was lost to mastectomy, and preserving muscle at the donor site. The most common option for perforator flap surgery is to use the abdomen as the donor site, transferring fat, skin, and blood vessels and sometimes the nerves from the lower abdomen to the chest to build the new breast and restore sensation.

“Natural tissue (or autologous) breast reconstruction using the patient’s own tissue provides the best aesthetic and longest-lasting result,” says Dr. Chen, “whether performed at the time of mastectomy or later, often as the result of failed implants. And the most frequent donor site for reconstructed breasts is the abdomen. A woman who has undergone a tummy tuck cannot undergo natural tissue breast reconstruction using her abdominal donor site.” That said, when the abdomen is used for natural tissue breast reconstruction, the end result is a flatter stomach as in a cosmetic abdominoplasty. Furthermore, natural tissue breast reconstruction using an abdominal donor site is paid for by insurance.

“With foresight, women can preserve their options for breast reconstruction, should that ever become necessary,” Dr. Chen concludes. “We have made great strides in advancing the surgical techniques that make this possible and women must be aware of their options and work with their surgeons to determine the solution that works best for them.”

Constance M. Chen, MD, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. She is Clinical Assistant Professor of Surgery (Plastic Surgery) at Weill Cornell Medical College and Clinical Assistant Professor of Surgery (Plastic Surgery) at Tulane University School of Medicine. http://www.constancechenmd.com 212-792-6378

Share article on social media or email:

Startup opens private AI system to help emergency professionals and local communities solve COVID-19 problems


dMASS Innovations Data for COVID19

We expect the innovations collected in this crisis to be useful in future emergencies as well.

dMASS, an early-stage company based in Austin, Texas, has developed a patented technology for identifying and curating thousands of innovations being developed by startups and large companies, engineers, and scientists around the world.

The technology was designed to automate the way that businesses identify emerging technologies, adapt to changing conditions, and build a more sustainable economy. Now, the company has decided to open its AI platform to help with the immediate crisis of COVID-19.

According to Kathryn Lewis, dMASS CEO, “As the COVID-19 pandemic has grown, we sought to use our capabilities in the fight against the virus and its devastating impacts. We have spent years tracking innovations that have the potential to build a more sustainable future. The COVID-19 pandemic, like sustainability is a global challenge. So, we decided to open our platform to help.”

The data system includes cutting-edge research, technology innovations, and creative business models that companies use to improve operational performance. In response to the crisis, the company has focused on curating innovations that can make a difference on the front-lines of the pandemic.

The company recently released a free version of the platform to connect emergency managers with the lifesaving innovations that address critical problems. Topics range from decentralized healthcare and last mile deliveries to medical device and PPE shortages. From companies making portable emergency rooms, to drones for delivering materials, or 3D printers replenishing critical supplies, the searchable data system is putting real-world solutions at the fingertips of public interest organizations.

“As the database grows, we expect the innovations collected during this crisis to be useful in future emergencies as well”, according to Lewis.

Emergency professionals can gain full access to the Innovation Engine’s features and data by contacting dMASS at info@dmass.net.

About dMASS

dMASS is a social venture based in Austin, Texas. The company has developed a patented technology to find, curate, and track thousands of innovations being developed by startups and large companies, engineers and scientists around the world.

For more information about dMASS, including example innovations, please visit platform.dmass.net or call 203-200-7749.

Share article on social media or email:

MEDPLI Now Offering Malpractice Insurance for Telemedicine Services


Physicians practicing telemedicine need to ensure they are protected by malpractice insurance that is underwritten by an A-rated carrier that understands the requirements and risks of telemedicine services, as well as the special circumstances of the COVID-19 pandemic.

In response to COVID-19 and the novel coronavirus pandemic, MEDPLI, a leading medical malpractice insurance provider, has started offering malpractice insurance for telemedicine services.

The COVID-19 pandemic and social distancing are forcing doctors to limit face-to-face interactions and use telemedicine to treat patients. Internet video technology has made it possible for doctors to virtually see patients for chronic disease management, preventative care, follow-up visits and more. SARS-CoV-2’s high communicability has made telemedicine a safer and more pragmatic way to see patients, protecting medical staff and reducing the impact on the healthcare system.

Though telemedicine provides a safe and streamlined method for treating certain conditions, it carries the same liabilities as in-person medical exams. Physicians need to ensure they are protected by malpractice insurance that is underwritten by an A-rated carrier that understands the requirements and risks of telemedicine services, as well as the special circumstances of the COVID-19 pandemic.

“Telemedicine isn’t just for this moment in time,” says Max Schloemann, CEO of MEDPLI. “Though COVID-19 will eventually get under control, physicians are seeing benefits of telemedicine unrelated to social distancing. The technology market is responding to the need for robust video conferencing systems, helping to usher in this new age of medicine. Telemedicine can’t become a substitute for all doctor-patient interactions, but its convenience is making it a viable and preferred option.”

Given the variations in policy types and insurance providers, it’s important for physicians providing telemedicine to check their policy before assuming they are protected. It’s also important to work with a provider that understands the legal requirements of practicing telemedicine, and how COVID-19 is impacting those mandates.

“COVID-19 has caused some states to relax licensure requirements for practicing telemedicine,” explains Max Schloemann. “Any physician who plans to provide telemedicine in states where they aren’t licensed needs to make sure their insurance covers them for those states.”

MEDPLI is currently helping all healthcare providers obtain malpractice coverage for telemedicine. You can contact MEDPLI today for help obtaining malpractice insurance for telemedicine, private practice, tail insurance, and group coverage.

ABOUT MEDPLI

MEDPLI is an independent insurance practice specializing in medical professional liability insurance. Through our A-rated insurance partners, we provide insurance solutions to doctors and healthcare providers in the United States. Visit medpli.com to learn more about our products and services.

Share article on social media or email:

Helpful Habits You Can Start Today


Talk to a friend, family member or caregiver, and they’ll likely admit that stress is a part of their daily lives. In fact, more than one in three people worldwide report experiencing a lot of worry (39%) or stress (35%) during the day, according to Gallup’s 2019 Global Emotions Report. Especially for older adults, stress has the potential to impact long-term physical health, as well as mental stability. While it’s impossible to completely eliminate the stress we feel, there are proactive steps we can take today to help alleviate some of our worries.

“Aging can oftentimes feel like a roller coaster of emotions, especially as we are experiencing changes in our lifestyle or wellbeing,” said Lakelyn Hogan, gerontologist and caregiver advocate at Home Instead Senior Care. “While it is perfectly natural to feel anxious during changing and uncertain times, it’s important that we take a moment to reflect on our stress levels and think about healthy ways we can cope.”

We all have an opportunity to help move our mindset from a place of fear to a place of hope. Coping with stress and anxieties can be challenging as you grow older, but doing so can offer impressive benefits to long-term health, even in small ways. The numerous benefits include improved mood, more restful sleep, lowered blood pressure and a boosted immune system, among other things.

To better identify and reduce stress in our daily lives, Hogan recommends practicing these simple habits:


  • Practice mindfulness. Actively focusing on the good and understanding the triggers that set you off is key to identifying and mitigating stress. When feeling overwhelmed, take a moment to simply sit still and breathe deeply. Try to quiet negative thoughts by making a daily list of what’s good in your life and why you’re grateful.
  • Find happiness through health. A healthy diet and exercise can go a long way to improving mood and maintaining positivity in your life. When possible, dedicate 30 minutes a day to activities like stretching, walking around the neighborhood or relaxation yoga at home. Can’t find 30 minutes a day to exercise? Break it up into three 10-minute chunks. With today’s technology, you also can find activities to get you moving online or even “On Demand” workouts through your TV provider. Eating well can also impact wellbeing.
  • Build a support team. Surrounding yourself with positive friends and family is helpful when trying to stay upbeat yourself. When physical visits with loved ones aren’t possible, consider using video chat platforms like Skype, Zoom or the senior-friendly GrandPad, picking up the phone, or sending an old-fashioned letter or postcard. To forge new relationships in person, consider joining a club for older adults, having some of your meals with others or volunteering in your community.
  • Limit your news intake. While it is important to stay current, too much negative news can contribute to high stress levels. Choose a reputable source and commit to checking it once in the morning and afternoon, rather than grazing throughout the day. Consider keeping your mind engaged in other activities, such as reading, writing or a favorite hobby.
  • Laugh daily. A quick chuckle not only makes you feel good, its positive effects stay with you long after the laughter subsides. Research shows that laughter lowers stress hormones, relaxes muscles, improves mood and eases anxiety. Find activities that encourage laughter throughout the day, like reading a novel, catching up with a loved one or watching a funny video.

Whether it’s a quick stroll around the block or giving your grandchildren a call, start small by adding one or two of these tips to your regular routine. Once you feel ready, add more. After all, the best game plan to reduce stress is one that works with your preferences and lifestyle. For more tips and activities to relieve stress, visit http://www.caregiverstress.com/senior-activities/.

ABOUT HOME INSTEAD SENIOR CARE

Founded in 1994 in Omaha, Nebraska, the Home Instead Senior Care® franchise network provides personalized care, support and education to enhance the lives of aging adults and their families. Today, the network is the world’s leading provider of in-home care services for seniors, with more than 1,200 independently owned and operated franchises that provide more than 80 million hours of care annually throughout the United States and 12 other countries. Local Home Instead Senior Care offices employ approximately 90,000 CAREGivers℠ worldwide who provide basic support services that enable seniors to live safely and comfortably in their own homes for as long as possible. Home Instead Senior Care franchise owners partner with clients and their family members to help meet varied individual needs. Services span the care continuum – from providing personal care to specialized Alzheimer’s care and hospice support. Also available are family caregiver education and support resources.

Visit HomeInstead.com. Connect with us on Facebook and Twitter.

Share article on social media or email:



Former Informatica, YL Ventures CISO Joins BigID As New Chief Security Officer


BigID, the leader in data-centric personal data privacy and protection, today announced the appointment of Roger Hale to Chief Security Officer. As CSO, Roger brings more than 35 years of information security experience spanning venture capital, cloud, data management and more.

At BigID, Roger will be responsible for leading initiatives related to security and risk management, internal compliance, product innovation and industry evangelism. Prior to BigID, Roger served as CISO-in-Residence at YL Ventures, advising early-stage startups on ideation support, product incubation and driving sales growth. Before joining YL Ventures, Roger was the Vice President and Chief Information Security Officer at Informatica, helping to build and lead security initiatives to bolster Informatica’s big data platform. He also previously served as the CISO at Inkling, and held senior leadership positions at Lending Club and Symantec.

“The breadth of Roger’s expertise makes him an ideal candidate to accelerate BigID’s security initiatives” said Dimitri Sirota, Co-founder and CEO of BigID. “He has a proven track record of spearheading robust in-house security policies and security-focused innovation, and will serve as a crucial member of our team as BigID enters its next stage of corporate growth.”

To learn more, please visit http://bigid.com/demo.

About BigID

Based in New York and Tel Aviv, BigID uses advanced machine learning and identity intelligence to help enterprises better protect their customer and employee data at petabyte scale. Using BigID, enterprises can better safeguard and assure the privacy of their most sensitive data, reducing breach risk and enabling compliance with emerging data protection regulations like the EU’s General Data Protection Regulation and California Consumer Privacy Act. BigID has raised $146 million in funding since its founding in 2016 and has been recognized for its privacy innovation as the 2018 RSA Conference Innovation Sandbox winner, a CB Insights 2018 Cyber Defender, Network Products Guide 2018 IT World Awards “Hot Company of the Year” winner, a 2019 InformationWeek Vendor to Watch, a 2019 Business Insider enterprise vendor “to bet your career on,” and a 2019 World Economic Forum Technology Pioneer. Learn more at http://bigid.com or visit us at http://bigid.com/demo to schedule a demo.

Share article on social media or email:

Osteopathic Medical Schools Adapt Admissions Processes in Response to COVID-19


Students are trying to make one of the biggest decisions of their lives in the middle of a global crisis. Our goal is to ensure that through these difficult times, we give the next generation of doctors clear guidance for application and acceptance into medical school.

Member medical schools of the American Association of Colleges of Osteopathic Medicine (AACOM) intend to adapt the application review process for all medical schools participating in the AACOMAS application process. These changes have been approved by AACOM’s Board of Deans to mitigate obstacles prospective students may confront as a result of the COVID-19 pandemic.

“The changes demonstrate to applicants that the osteopathic community truly lives by a holistic philosophy, we understand their circumstances, and we are willing to be flexible,” said Jayme Bograd, Director of Application Services, Recruitment, and Student Affairs. “Students are trying to make one of the biggest decisions of their lives in the middle of a global crisis. Our goal is to ensure that through these difficult times, we give the next generation of doctors clear guidance for application and acceptance into medical school.”

Congruent with the osteopathic medical profession’s philosophy, AACOMAS participating schools intend to adapt their application review process to allow for greater flexibility in accepting online coursework, accepting pass/fail/satisfactory/unsatisfactory coursework, and reviewing applications prior to receiving MCAT scores. Please refer to AACOM’s newly released letter to future applicants for details regarding these changes. AACOM will continue to guide its osteopathic medical schools as the needs of prospective students evolve.

The application for the 2021 entering class opens on May 5, 2020. Visit ChooseDO.org for more information.

About AACOM

The American Association of Colleges of Osteopathic Medicine (AACOM) was founded in 1898 to lend support and assistance to the nation’s osteopathic medical schools, and to serve as a unifying voice for osteopathic medical education.

Having grown from a handful of college administrators a century ago, the organization today represents the administration, faculty, and students of all osteopathic medical colleges in the United States. The association, guided by its Board of Deans and various other member councils and committees, is actively involved in all areas of osteopathic medical education.

Share article on social media or email:

USA Fibroid Centers Now Offer the Safety and Convenience of Telemedicine Consultations During the COVID-19 Pandemic


If you are suffering from the negative effects of fibroids, we encourage you to book a virtual appointment with one of our specialists to explore your options

USA Fibroid Centers, a national network of outpatient fibroid treatment centers, is pleased to announce the introduction of telemedicine. Patients can now book a virtual doctor appointment online with a specialist to discuss fibroid symptoms and potential treatment options –– all from the comfort and safety of their own home.

“We understand that patients are hesitant right now to seek out treatment for underlying conditions like uterine fibroids,” says Yan Katsnelson, MD, Co-Founder of USA Fibroid Centers. “However, if left untreated, these growths have the potential to cause painful and uncomfortable symptoms, harm surrounding organs, and even impact fertility. If you are suffering from the negative effects of fibroids, we encourage you to book a virtual appointment with one of our specialists to explore your options.”

USA Fibroid Centers’ telemedicine appointments offer the same high-quality care as an office visit, are covered by most health insurance plans, and are much more convenient for those sheltering in place. If it is deemed medically necessary to proceed with fibroid treatment during the COVID-19 crisis, patients can be assured that all clinic locations are following strict precautionary measures in an attempt to keep their facilities safe and maintain a virus-free environment.

To request a USA Fibroid Centers telemedicine appointment, please visit https://www.usafibroidcenters.com/telemedicine-virtual-consultation-request/.

About Uterine Fibroids:

Uterine fibroids are a type of noncancerous growth that commonly develop during the reproductive years. As many as 80% of women are affected by age 50. Although not generally considered dangerous, fibroids can cause a range of symptoms including heavy menstrual periods, severe pelvic cramping, frequent urination, and pain during sexual intercourse. Not all patients experience symptoms. Fibroids can develop individually or as multiples, and range in size from a tiny pea to a melon. Treatment is generally recommended when symptoms interfere with career, social interactions, relationships, or self-esteem.

About USA Fibroid Centers:

USA Fibroid Centers is one of the nation’s only networks of medical treatment facilities that exclusively offers non-surgical fibroid treatment. Their top-rated experts aim to educate patients on their full range of available fibroid treatments, while providing a state-of-the-art, non-surgical solution for fibroid symptoms called Uterine Fibroid Embolization (UFE). UFE takes only 30 to 45 minutes and allows patients to return home the same day. To learn more, please visit https://www.usafibroidcenters.com/.

Share article on social media or email:

Actuate Therapeutics Announces Initiation of Additional Clinical Studies for 9-ING-41


Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced the initiation of two additional clinical studies with its lead molecule, 9-ING-41, a Glycogen Synthase Kinase beta (GSK-3β) inhibitor.

On April 8, the company opened its 1902 study: A Phase 1 study of 9-ING-41, a Glycogen Synthase Kinase 3 Beta (GSK 3β) inhibitor, as a single agent or with Irinotecan in pediatric patients with refractory malignancies. Study 1902 will serve as the required Phase 1 safety study prior to initiating Phase 2 studies for treatment of pediatric patients including those with neuroblastoma, for which the company has received both Orphan Drug and Rare Pediatric Disease Designations from the FDA.

“GSK-3β is well established as a potentially important therapeutic target in patients with neuroblastoma, a malignancy in which there is an urgent need for novel approaches”, said Ludimila Cavalcante, MD, Lead Medical Affairs at Actuate. “Multiple investigators have confirmed the activity of 9-ING-41 in pre-clinical models of MYC-N amplified and non-amplified disease, both as a single agent and when combined with cytotoxic therapies. The 1902 study will provide the cornerstone pediatric safety data needed to conduct tumor-specific Phase 2 studies. Aside from direct anti-tumor activity against neuroblastoma, GSK-3β inhibition of PD1 and LAG-3 expression may be reversed by 9-ING-41, which is potentially important in relatively nonimmunogenic cancers, including neuroblastoma.”

The company has also recently opened its 1901 study: A Phase 2 study of 9-ING-41, a Glycogen Synthase Kinase 3 Beta (GSK 3β) inhibitor, as a single agent or combined with Ruxolitinib, in patients with myelofibrosis.

“9-ING-41 may help to address the major unmet medical need for new treatment options for patients with myelofibrosis”, said Frank Giles, MD, Chief Medical Officer of Actuate. “Achieving sustained adequate exposure to JAK inhibitors is necessary for optimal therapeutic outcomes but adverse events, particularly myelosuppression, lead to frustrating and damaging dose reductions or interruptions in many patients. 9-ING-41 has clinical anti-neoplastic activity, significant pre-clinical anti-fibrotic activity, causes no myelosuppression, and is synergistic pre-clinically with Ruxolitinib. It is very exciting to have a unique investigational option to offer patients with an agent that is likely to be synergistic with other novel therapeutic approaches being developed for myelofibrosis.”

“We are particularly fortunate to be able to advance multiple clinical programs in such a challenging environment. With 9-ING-41’s favorable safety profile, including the lack of immunosuppression or myelosuppression in patients with diverse advanced malignancies, our clinical collaborators are committed to accrual on both current and new studies”. said Daniel Schmitt, President & CEO. “We are able to maintain the momentum of our programs during these very adverse conditions and are very grateful to work with superb clinical and pre-clinical colleagues whose unwavering focus is on improving the prognosis for patients, both adults and children, with cancer.”

About Actuate Therapeutics, Inc.

Actuate is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics for cancers and inflammatory diseases. For additional information, please visit the Company’s website at http://www.actuatetherapeutics.com

Share article on social media or email: